Sandro graduated from Porto University in Portugal with a PhD in Biomedical Sciences and was a Postdoctoral Fellow at the IPBS-CNRS in Toulouse, France, where he investigated new compounds to modulate the inflammatory response. He joined GSK’s Cell & Gene Therapy, Product Development, in 2016, where he works to deliver the CMC aspects of different projects from early phase to launch and the development of innovative technologies to enable step-change improvements to cell & gene therapy manufacture. Sandro specializes in Cell Process Development, seeking to optimize the manufacture of cell and gene therapy based treatments, using increased automation and leading-edge processing technology
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.